<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8267">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02999321</url>
  </required_header>
  <id_info>
    <org_study_id>055-045</org_study_id>
    <nct_id>NCT02999321</nct_id>
  </id_info>
  <brief_title>The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance</brief_title>
  <official_title>The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ajinomoto USA, INC.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Purdue University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg
      aspartame. Participants will have an oral glucose tolerance test at the beginning and end of
      a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up
      their next week's intervention products and measurements for body weight, waist
      circumference, blood pressure and heart rate. They will consume their intervention products
      daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample
      at weeks 0, 4, 8, and 12.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change oral glucose tolerance</measure>
    <time_frame>4 hours</time_frame>
    <description>samples taken at 0, 15, 30, 60, 90, 120, 180and 240 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appetite</measure>
    <time_frame>every hour for 1 day at weeks 0, 4, 8 and 12</time_frame>
    <description>questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day during weeks 0, 4, 8 and 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>week 0 and week 12</time_frame>
    <description>body composition measurement Plysmography (BOD POD) done at week 0 and at week 12.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Oral Glucose Tolerance</condition>
  <arm_group>
    <arm_group_label>0% aspartame (water)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will not have any aspartame, this is a control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 mg aspartame</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will receive 5 mg aspartame in a beverage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15mg aspartame</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will receive 5 mg aspartame in a beverage, and 10mg in capsules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>aspartame</intervention_name>
    <description>will be given 5mg aspartame or 15 mg aspartame</description>
    <arm_group_label>5 mg aspartame</arm_group_label>
    <arm_group_label>15mg aspartame</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>water</intervention_name>
    <description>control group</description>
    <arm_group_label>0% aspartame (water)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 18-25, fasting blood sugar between 72 and 108 mg/dl via capillary finger-stick.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard D Mattes, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Purdue University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Mattes, PhD</last_name>
    <phone>765-494-0662</phone>
    <email>mattes@purdue.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Purdue Univeristy</name>
      <address>
        <city>W. Lafayette</city>
        <state>Indiana</state>
        <zip>47907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard D Mattes, PhD</last_name>
      <phone>765-494-0662</phone>
      <email>mattes@purdue.edu</email>
    </contact>
    <investigator>
      <last_name>Richard D Mattes, MPH, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 20, 2016</lastchanged_date>
  <firstreceived_date>December 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Purdue University</investigator_affiliation>
    <investigator_full_name>Richard Mattes</investigator_full_name>
    <investigator_title>Professor of Nutrition Sciences</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
